$DFFN “We will announce the topline, safety and tolerability data for the final dose group promptly following completion of the committee’s evaluation. Analyses of the secondary endpoint data are anticipated to be completed and announced before the end of the first quarter of 2021.” Once positive data is announced, the next move will definitely involve FDA clearance for either EUA or actual approval for use of TSC in Covid patients. Now Pinky are you pondering what I’m pondering 🤑🤑🤑Bullish all the way 🚀🚀🚀
2
2
2 Likes